Drug firm Nectar Lifesciences today said its net profit declined by 28.46% to Rs 11.21 crore for the quarter ended June 30.
The company had posted a net profit of Rs 15.67 crore for the quarter ended June 30, 2010 Nectar Lifesciences said in a filing to the Bombay Stock Exchange (BSE).
Net sales of the company stood at Rs 208.89 crore for the quarter ended June 30, 2011 as against Rs 181.24 crore for the same period last fiscal.
The company's board has also recommended 10% final dividend to the members of the company, out of profits of the company for the financial year 2010-11, Nectar Lifesciences said in a separate filing.
Shares of Nectar Lifesciences today closed at Rs 21 on the BSE, down 1.87% from its previous close.
